Skip to main content
. 2020 Apr 29;76(Pt 5):216–221. doi: 10.1107/S2053230X20005452

Table 2. Crystallization.

  Form 1 Form 2 Form 3 Form 4
Protein concentration (mg ml−1) 9.0 11.0 11.0 14.0
Buffer composition of protein solution 10 mM Tris–HCl pH 8.0, 10 mM CaCl2 10 mM Tris–HCl pH 8.0, 10 mM CaCl2, 2 mM FV peptide (929–937, SDLLLLKQS) 10 mM Tris–HCl pH 8.0, 10 mM CaCl2, 2 mM FV peptide (929–937, SDLLLLKQS) 10 mM Tris–HCl pH 8.0, 10 mM CaCl2,, 2.5 mM FVIII peptide (776–816)
Composition of reservoir solution 1.2 M sodium malonate, 0.5%(v/v) Jeffamine ED-2001, 50 mM Tris–HCl pH 7.0 17% PEG 8000, 8% ethylene glycol, 0.1 M Tris–HCl pH 8.5 19% PEG 3350, 8% ethylene glycol, 0.1 M bis-Tris pH 6.0 1.1 M sodium malonate, 0.5%(v/v) Jeffamine ED-2001, 0.1 M HEPES pH 7.0